Information Provided By:
Fly News Breaks for September 4, 2018
SMLR
Sep 4, 2018 | 08:51 EDT
Lake Street analyst Brooks O'Neil raised his price target for Semler Scientific to $40 citing the company's "large market opportunity." Semler offers an unrivaled product in an expanding, underpenetrated market, O'Neil tells investors in a research note. He believes Semler has developed a unique tool for diagnosing peripheral artery disease, which he calls a serious and common condition in which 80% of patients are asymptomatic. He thinks the company "can deliver strong revenue growth over time."
News For SMLR From the Last 2 Days
There are no results for your query SMLR